Sponsor: QIAGEN. This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
Akers Biosciences inked a joint venture agreement with Hainan Savy Investment Management to research, develop, produce, and sell certain Akers’ rapid diagnostic screening and...
Researchers report that approaches using precision medicine for cancer treatment, showed improved response and longer periods of remission.
Philips Unveils Expanded Visualization Platform, Leads Liquid Biopsy/MRI Consortium in Winning EU Grant
Royal Philips launches next-gen IntelliSpace Portal 10 platform and leads liquid biopsy/MRI consortium in winning $7.5M from EU
Colorectal cancer is the second-leading cause of death (behind only lung cancer) among men and women in the United States; 49,700 people are expected...
Astute gains wider access to Bio-Techne's antibody and protein libraries, and Bio-Techne receives manufacturing rights for future products.
Company aims to improve prediction of chronic disorders from a single blood sample by measuring more than 220 blood metabolic biomarkers.
Launched in 2012 by then Prime Minister David Cameron, the project is the centerpiece of NHS's Genomic Medicine Service unveiled in October
Genospace's cloud-based precision medicine tools will allow Sarah Cannon to more effectively match patients with targeted clinical trials.
Big data reveals overlapping genetic mutations in cancer cell lines and patient tumors that may help advance precision cancer treatment.